PDX Portal

Pancreas Collection

Patient Clinical View
Gene View

Filter Data:

PDX (22)

Patients (22)

Collection Summaries:

Collection Details:

Model IDFilter by Model ID	Patient IDFilter by Patient ID	Pathology Diagnosis Select Pancreatic ductal adenocarcinoma Adenocarcinoma (pancreatobiliary) High grade Adenocarcinoma	Patient Biomarkers			NCCN Stage Select Resectable Borderline Metastatic	BMI Select >35 20-25 30-35 <20 25-30	Survival in MonthsFilter by Survival in Months	Age at Diagnosis Select 60-70 >70 50-60 40-50	Race Select White Black or African American White,Hispanic or Latino Asian Hispanic or Latino	Gender Select Female Male	Grade Select G2.5 Not Reported G2 G3 G4	Stage Select IIA IIB III IB IV	Patient TreatmentFilter by Patient Treatment
Model IDFilter by Model ID	Patient IDFilter by Patient ID		CA 19-9Filter by CA 19-9	BilirubinFilter by Bilirubin	Risk FactorFilter by Risk Factor	NCCN Stage Select Resectable Borderline Metastatic	BMI Select >35 20-25 30-35 <20 25-30	Survival in MonthsFilter by Survival in Months	Age at Diagnosis Select 60-70 >70 50-60 40-50		Gender Select Female Male	Grade Select G2.5 Not Reported G2 G3 G4	Stage Select IIA IIB III IB IV	Patient TreatmentFilter by Patient Treatment
BCM-PDAC-1	4622397	Pancreatic ductal adenocarcinoma	79.2	3.5	Tobacco	Borderline	21.3	55	58.43	White	Male	G2	IIB	Abraxane,Capecitabine,Gemcitabine
BCM-PDAC-10	5695792	Pancreatic ductal adenocarcinoma	79	0.8	Tobacco, Pancreatitis	Resectable	21.0	27	58.14	White	Female	G2	IIB	Folfirinox
BCM-PDAC-11	6046120	High grade Adenocarcinoma	421	22.7	Tobacco, Pancreatitis	Resectable	23.75	23	59.9	White	Male	G3	IIB	Abraxane,Capecitabine,Folfirinox,Folfox,Gemcitabine
BCM-PDAC-13	6125394	Pancreatic ductal adenocarcinoma	106	0.2	Diabetes, Tobacco, Pancreatitis	Resectable	22.5	14	64.75	Hispanic or Latino	Male	G3	IIB	Abraxane,Gemcitabine
BCM-PDAC-14	6142831	Pancreatic ductal adenocarcinoma	401.2	0.5	Diabetes	Resectable	40.05	12	64.32	White	Female	G2	IIB	Gemcitabine
BCM-PDAC-18	6652135	Pancreatic ductal adenocarcinoma	1542	0.5	Diabetes	Resectable	30.75	42	65.02	White	Male	G2	IIB	Abraxane,Capecitabine,Gemcitabine
BCM-PDAC-19	6714659	Pancreatic ductal adenocarcinoma	2600	2.4	Tobacco, Diabetes	Resectable	29.3	17	71.97	White	Female	G2	IIB	Gemcitabine
BCM-PDAC-2	4639492	Pancreatic ductal adenocarcinoma	192.2	0.6	Tobacco	Resectable	22.24	15	88.58	White	Male	G2	IIB
BCM-PDAC-25	8471998	Pancreatic ductal adenocarcinoma	988	16.5		Resectable	39.0	6	66.13	White	Male	G3	IIB	folfirinox
BCM-PDAC-26	8635396	Pancreatic ductal adenocarcinoma	186	0.6		Resectable	22.06	15	46.68	Black or African American	Female	G2	IIB	Gemcitabine,capecitabine
BCM-PDAC-28	8944795	Adenocarcinoma (pancreatobiliary)	78	6.6	Tobacco	Resectable	28.11	21	59.08	White	Male	G2.5	IV	Abraxane with investigational agent (HALO 301),Gemcitabine
BCM-PDAC-29	8988670	Pancreatic ductal adenocarcinoma	534	0.3	Diabetes, Tobacco, Pancreatitis	Resectable	47.01	28	65.43	Black or African American	Female	G2	IIA	Abraxane,Capecitabine,Gemcitabine,capecitabine
BCM-PDAC-3	4642227	Pancreatic ductal adenocarcinoma	540	0.3	Tobacco	Metastatic	23.8	0	65.45	White	Female		IV
BCM-PDAC-30	8979334	Pancreatic ductal adenocarcinoma		Unknown	Diabetes, Tobacco	Resectable	23.2	9	76.87	White	Female	G2	IIB	Gemcitabine,capecitabine
BCM-PDAC-31	9545904	Pancreatic ductal adenocarcinoma		Unknown	Diabetes	Resectable	26.79	9	68.68	White,Hispanic or Latino	Female	G4	IIB	Abraxane,Gemcitabine

* indicates the model is private.

Gene Expression Plot:

Copy Number Variation Plot:

Mutation Plot:

SITE LINKS

Contact Us
Portal Team
Log In
Baylor College of Medicine
Advanced In Vivo Models Unit

COLLECTIONS

Breast
Pediatric Liver
Pancreas
Leukemia
Sarcoma

CONTACT

PDX Development Unit
Advanced In Vivo Models Unit
PDX Pediatric Liver Program

© 2019 Biomedical Informatics Group, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine